Clinical Trial Update: Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 trial update reports long-term use (one year) of alefacept (Amevive) in moderate to severe chronic plaque psoriasis; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Amevive (alefacept)

Snippet

Sponsor: Wake Forest University | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2012-08-03